1Lauer G M,Walker B D. Hepatitis C vires infection[J]. N Engl J Med, 2001 ; 345( 1 ) :41-52.
2Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium[J]. J Viral Hepat, 1999;6( 1 ), 35-47.
3Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection[ J ]. Nat Rev Immunol, 2005 ; 5 (3) : 215-229.
4Sugimoto K, Stadanlick J, Ikeda F etal. lnfluence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response[ J]. Hepatology, 2003 ; 37 (3) : 590-599.
5Kato N. Genome of hurrah hepatitis C virus (HCV) : gene organization, sequence diversity, and variation[J]. Microb Comp Genomics,2000;5 : 129-151.
6Bain C, Parroche P, Lavergne J Pet al. Memory T-cell-mediated immune response specific to an alternative core protein in hepatitis C virus infection[ J]. Virol, 2004 ; 78 (19) : 10460-10469.
7Shoukry N H, GraKoui A, Houghton M. Memory CD8 ^+ T cells are required for protection from persistent hepatitis C virus infection [J]. J Exp Med, 2003 ; 197(12) : 1645-1655.
8Diepolder H M, Zachoval R, Hoffmann R Met al. Possible mechanisminvolving T-lymphocyte response to non-structural protein 3 in viral clearance inacute hepatitis C virus infection[J], Lance, 1995;346:1006-1007.
9Julin Schulze zur Wiesch, Victoria et al. Ex vivo analysis of CD4+ T helper cell response in acute HCV infection and early treatment [ J]. Hepatology,2008 ;48(4) :401A.
10Seddiki N,Santner-Nanan B,Martinson J et al. Barbara Fazekas de St. Groth. Expression of interleukin (IL)-2 and IL-7 receptors discriminates belween human regulatory and activated T calls[ J ]. J Exd Med, 2006; 203(7) : 1693-1700.
